Publications - Information

News

News

Publication ButtonCHI St. Alexius Health welcomes media professionals to work with the media relations team to arrange interviews and stories and to visit the facilities. If you are a member of the media and would like to speak to a member of our media relations team, please click here.
 

Bismarck utilizing newly FDA-authorized COVID-19 treatment drug

“Any treatment options that we have at all that can keep someone healthy and prevent them from getting very, very sick and even potentially pass away from COVID is a huge win,” Dr. Khalin Dendy, Internal Medicine Physician said. Within the past two weeks, several North Dakota hospitals have implemented treatment of the newly FDA-authorized experimental drug bamlanivimab, and doctors say they’re eager to see it put to work.

Bismarck utilizing newly FDA-authorized COVID-19 treatment drug

Prediabetes: A Silent but Serious Health Warning

If the road ahead went off a cliff, you’d turn around in time. That’s the upside of getting a diagnosis of prediabetes.  Finding out you have prediabetes gives you time to turn around and decrease your risk of developing type 2 diabetes in the future, as well as heart disease and stroke. An estimated 1 in 3 Americans has prediabetes, and more than 84 percent are completely unaware because it causes no noticeable symptoms. You can feel perfectly fine and still have prediabetes.

Prediabetes: A Silent but Serious Health Warning

Bismarck Purchases Respiratory Helmets for COVID Patients

CHI St. Alexius Health is excited to offer another tool to help COVID-19 patients suffering from acute respiratory distress. The device is a respiratory helmet that will improve oxygen flow and allow the critically ill patients to breathe easier, remain conscious and avoid intubation.

Bismarck Purchases Respiratory Helmets for COVID Patients

Williston Pharmacist Receives Statewide Honor

CHI St. Alexius Health Pharmacist is Honored

FDA approves new COVID drug

FDA approves new COVID drug for mild cases under emergency use authorization

There’s a new drug approved for treatment of COVID-19. And, you might have heard about it before. Regeneron Pharmaceuticals Incorporated recently got the “okay” from the Food and Drug Administration for its “COVID cocktail” that President Donald Trump was prescribed about a month ago. The FDA cleared Regeneron’s antibody treatment on Saturday for emergency use in COVID-positive patients with mild to moderate symptoms. The company’s CEO reported Monday, Regeneron will provide the U.S. with 300,000 doses of the drug.

FDA approves new COVID drug

Traveling Nurse gets shocking diagnosis in ND

Traveling nurse gets shocking diagnosis while helping with coronavirus efforts in North Dakota

A traveling nurse from the east coast who made her way to North Dakota to help out with the coronavirus efforts received a shocking diagnosis, but she’s still remaining positive through it all. “It’s pretty surreal and unbelievable how all of it happened,” said Helene Neville, a traveling nurse. She arrived in Bismarck on September 7 to help out with the coronavirus efforts. She says she was working three to four 12 hour shifts every week until mid-October. Then, she started feeling tired and decided to go to the ER, where she was greeted by a nurse.

Traveling Nurse gets shocking diagnosis in ND

Traveling Nurse working in Bismarck

KX Conversation: Ebonie Siemer, a traveling nurse from Florida working in a Bismarck hospital. Ebonie Siemer, a traveling nurse from Florida who is working at a Bismarck hospital, joins Nov. 25’s KX Conversation after a patient of hers, who was extremely ill with COVID-19, called our station with an amazing review of Ebonie.

Traveling Nurse working in Bismarck

Dickinson Employee's Greatest Blessing

From the Spring 2020 Edition of Firm Founadtions - A Publication of CHI St. Alexius Health Dickinson Foundation: